Tracey Ying1,2,3, Bree Shi1,2,3, Patrick J Kelly4, Helen Pilmore5, Philip A Clayton6,2,3,7,8, Steven J Chadban6,2,3. 1. Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Camperdown, Australia tracey.ying@sydney.edu.au. 2. Kidney Node, Charles Perkins Centre, The University of Sydney, Sydney, Australia. 3. Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia. 4. School of Public Health, The University of Sydney, Sydney, Australia. 5. Renal Department, Auckland City Hospital, Auckland, New Zealand. 6. Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Camperdown, Australia. 7. Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia. 8. Adelaide Medical School, University of Adelaide, Adelaide, Australia.
Abstract
BACKGROUND: Mortality risk after kidney transplantation can vary significantly during the post-transplant course. A contemporary assessment of trends in all-cause and cause-specific mortality at different periods post-transplant is required to better inform patients, clinicians, researchers, and policy makers. METHODS: We included all first kidney-only transplant recipients from 1980 through 2018 from the Australia and New Zealand Dialysis and Transplant Registry. We compared adjusted death rates per 5-year intervals, using a piecewise exponential survival model, stratified by time post-transplant or time post-graft failure. RESULTS: Of 23,210 recipients, 4765 died with a functioning graft. Risk of death declined over successive eras, at all periods post-transplant. Reductions in early deaths were most marked; however, recipients ≥10 years post-transplant were 20% less likely to die in the current era compared with preceding eras (2015-2018 versus 2005-2009, adjusted hazard ratio, 0.80; 95% confidence interval, 0.69 to 0.90). In 2015-2018, cardiovascular disease was the most common cause of death, particularly in months 0-3 post-transplant (1.18 per 100 patient-years). Cancer deaths were rare early post-transplant, but frequent at later time points (0.93 per 100 patient-years ≥10 years post-transplant). Among 3657 patients with first graft loss, 2472 died and were not retransplanted. Death was common in the first year after graft failure, and the cause was most commonly cardiovascular (50%). CONCLUSIONS: Reductions in death early and late post-transplant over the past 40 years represent a major achievement. Reductions in cause-specific mortality at all time points post-transplant are also apparent. However, relatively greater reductions in cardiovascular death have increased the prominence of late cancer deaths.
BACKGROUND:Mortality risk after kidney transplantation can vary significantly during the post-transplant course. A contemporary assessment of trends in all-cause and cause-specific mortality at different periods post-transplant is required to better inform patients, clinicians, researchers, and policy makers. METHODS: We included all first kidney-only transplant recipients from 1980 through 2018 from the Australia and New Zealand Dialysis and Transplant Registry. We compared adjusted death rates per 5-year intervals, using a piecewise exponential survival model, stratified by time post-transplant or time post-graft failure. RESULTS: Of 23,210 recipients, 4765 died with a functioning graft. Risk of death declined over successive eras, at all periods post-transplant. Reductions in early deaths were most marked; however, recipients ≥10 years post-transplant were 20% less likely to die in the current era compared with preceding eras (2015-2018 versus 2005-2009, adjusted hazard ratio, 0.80; 95% confidence interval, 0.69 to 0.90). In 2015-2018, cardiovascular disease was the most common cause of death, particularly in months 0-3 post-transplant (1.18 per 100 patient-years). Cancer deaths were rare early post-transplant, but frequent at later time points (0.93 per 100 patient-years ≥10 years post-transplant). Among 3657 patients with first graft loss, 2472 died and were not retransplanted. Death was common in the first year after graft failure, and the cause was most commonly cardiovascular (50%). CONCLUSIONS: Reductions in death early and late post-transplant over the past 40 years represent a major achievement. Reductions in cause-specific mortality at all time points post-transplant are also apparent. However, relatively greater reductions in cardiovascular death have increased the prominence of late cancer deaths.
Authors: Bénédicte Sautenet; Allison Tong; Karine E Manera; Jeremy R Chapman; Anthony N Warrens; David Rosenbloom; Germaine Wong; John Gill; Klemens Budde; Lionel Rostaing; Lorna Marson; Michelle A Josephson; Peter P Reese; Timothy L Pruett; Camilla S Hanson; Donal O'Donoghue; Helen Tam-Tham; Jean-Michel Halimi; Jenny I Shen; John Kanellis; John D Scandling; Kirsten Howard; Martin Howell; Nick Cross; Nicole Evangelidis; Philip Masson; Rainer Oberbauer; Samuel Fung; Shilpa Jesudason; Simon Knight; Sreedhar Mandayam; Stephen P McDonald; Steve Chadban; Tasleem Rajan; Jonathan C Craig Journal: Transplantation Date: 2017-08 Impact factor: 4.939
Authors: Anna Francis; David W Johnson; Anette Melk; Bethany J Foster; Katrina Blazek; Jonathan C Craig; Germaine Wong Journal: Clin J Am Soc Nephrol Date: 2020-02-19 Impact factor: 8.237
Authors: Matthew P Sypek; Kathryn B Dansie; Phil Clayton; Angela C Webster; Stephen Mcdonald Journal: Nephrology (Carlton) Date: 2019-03 Impact factor: 2.506
Authors: Mark R Marshall; Kevan R Polkinghorne; Peter G Kerr; John W M Agar; Carmel M Hawley; Stephen P McDonald Journal: Am J Kidney Dis Date: 2015-05-06 Impact factor: 8.860
Authors: Colin Baigent; William G Herrington; Josef Coresh; Martin J Landray; Adeera Levin; Vlado Perkovic; Marc A Pfeffer; Peter Rossing; Michael Walsh; Christoph Wanner; David C Wheeler; Wolfgang C Winkelmayer; John J V McMurray Journal: Kidney Int Date: 2017-08 Impact factor: 10.612
Authors: Ulrich Jehn; Katharina Schütte-Nütgen; Markus Strauss; Jan Kunert; Hermann Pavenstädt; Gerold Thölking; Barbara Suwelack; Stefan Reuter Journal: J Clin Med Date: 2020-12-07 Impact factor: 4.241
Authors: Xingxing S Cheng; Daniel J Watford; Hiroyuki Arashi; Margaret R Stedman; Glenn M Chertow; Jane C Tan; William F Fearon Journal: Cardiorenal Med Date: 2021-05-25 Impact factor: 4.360
Authors: Massini A Merzkani; Andrew J Bentall; Byron H Smith; Xiomara Benavides Lopez; Matthew R D'Costa; Walter D Park; Walter K Kremers; Naim Issa; Andrew D Rule; Harini Chakkera; Kunam Reddy; Hasan Khamash; Hani M Wadei; Martin Mai; Mariam P Alexander; Hatem Amer; Aleksandra Kukla; Mireille El Ters; Carrie A Schinstock; Manish J Gandhi; Raymond Heilman; Mark D Stegall Journal: Transplant Direct Date: 2022-01-13